Holon-S1

Holon-S1 is a recently tracked product, model, or tool in public channels. The radar excerpt reads:

SophontAI launched Holon-S1 (first product): pan-cancer model predicting spatial gene/pathway activity from routine H&E pathology slides. PR Newswire/Yahoo Oct 20; product page sophont.med/holon; CEO Tanishq Abraham on MTS. Circulating through Asia morning Oct 21; missed prior 08:32 insert.

The recorded source label is x+web. Use the public URL below to verify the original post or page.

Based only on the excerpt, Holon-S1 should be understood from the facts stated there. This write-up does not invent funding amounts, model sizes, or leaderboard scores that are absent from the excerpt or URL metadata.

Confirmable points from the excerpt:

• SophontAI launched Holon-S1 (first product): pan-cancer model predicting spatial gene/pathway activity from routine H&E pathology slides.

• PR Newswire/Yahoo Oct 20; product page sophont.med/holon; CEO Tanishq Abraham on MTS.

• Circulating through Asia morning Oct 21; missed prior 08:32 insert.

The radar score for this entry is 0.88 (an internal ranking field, not a third-party benchmark score).

To learn more or try Holon-S1, start from public sources:

1. Open the source link: https://sophont.med/holon/ and check the official description and availability.

2. Follow any access path mentioned in the excerpt (API, open weights, waitlist, in-product entry) using official instructions.

3. Before production use, verify license terms, regional availability, and safety limits yourself; do not assume quotas, prices, or eval scores that the excerpt does not state.